Reviva Pharmaceuticals Holdings - Warrants (25/12/2025) Net Tangible Assets

As of the most recent data (June 2026), RVPHW shows a net tangible assets of $15T. That compares with $-460K in the prior-year period — up 3312064645.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, RVPHW's net tangible assets is now $15T (was $-460K) — a 3312064645.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Reviva Pharmaceuticals Holdings - Warrants (25/12/2025) is outperforming or lagging.

Tracking RVPHW's net tangible assets over time shows whether Reviva Pharmaceuticals Holdings - Warrants (25/12/2025) is scaling, shrinking, or reshaping that part of the business. The current reading is $15T That compares with $-460K in the prior-year period — up 3312064645.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net tangible assets page, Stockcircle has Reviva Pharmaceuticals Holdings - Warrants (25/12/2025)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $15T) with ownership activity and broader fundamentals.

Reviva Pharmaceuticals Holdings - Warrants (25/12/2025)'s net tangible assets is $15T; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.